Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Wärtsilä signs second renewal of Maintenance Agreement with Rederi Ab Eckerö

Wärtsilä Corporation, Press release, 30 June 2021 at 10:00 AM EESTThe technology group Wärtsilä has renewed for the second time its Optimised Maintenance agreement with the Åland Islands based shipping group Rederi Ab Eckerö. Under the terms of this latest 5-year agreement, Wärtsilä will be responsible for maintenance of the main and auxiliary engines in six vessels within the customer’s fleet. Annual performance audits aimed at ensuring optimal operating efficiency will also be carried out. The agreement was signed in May 2021. “Our policy is to make every effort to maximise the

New study supports TEXEL’s energy storage alternative as a challenger to the lithium-ion battery

Developing inexpensive renewable energy, such as wind and solar, is one step toward a future with net-zero carbon energy. Creating cost-effective, reliable and sustainable energy storage is another. In a new study, Arizona State University (ASU) has evaluated market opportunities in the U.S. for the Swedish cleantech company TEXEL Energy Storage. According to the report TEXEL offers a lower cost alternative to lithium-ion batteries for the American market.In a new study, Arizona State University (ASU) evaluated U.S. market opportunities for TEXEL Energy Storage, a Swedish cleantech company.

ANNOUNCEMENT OF THE NAV OF P CAPITAL PARTNERS IV

Today the Net Asset Values of the P Capital Partners IV participation loan debentures is at the close of business on 29 June 2021 EUR 103.77 per each of the series A1 participation loan debentures. The Net Asset Value of P Capital Partners IV participation loan debentures is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The Net Asset Value has been set, as a result of P Capital Partners IV increasing its contributed capital by EUR 15.5 million, through the issuance of 154,240 series A1 participation loan debentures at a price of

Scandic rewards conscientious travelers - launches program to engage guests together with the Keep Sweden Tidy Foundation

The summer of 2021 is expected to focus on domestic travel. And as people are preparing to explore more areas of their home terrain, there are already reports of increased littering and fears of congestion at popular destinations this summer. To help address this, Scandic has launched a program that rewards travelers who show extra consideration for others and nature this summer.By committing to adhere to Scandic’s list of ten good habits for summer travel, travelers can earn points for future stays at Scandic hotels. The habits have been developed by Scandic’s sustainability department and

ANNOUNCEMENT OF THE NAV OF P CAPITAL PARTNERS IV B

Today the Net Asset Values of the P Capital Partners IV B participation loan debentures are being announced. At the close of business on 29 June 2021, the Net Asset Value of the series A1 participation loan debentures amounted to EUR 102.98 each, and the Net Asset Value of the series B participation loan debenture amounted to EUR 1,030.86 each. The Net Asset Value of P Capital Partners IV B participation loan debentures is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The Net Asset Value has been set as a result of P Capital

Medius delivers seamless cross-border payments with TransferMate

New partnership with TransferMate brings international payments with no international wire fees, making payments faster, simpler and cheaper.STOCKHOLM, June 30, 2021 – Medius , a leading provider of spend management solutions, is announcing its partnership with TransferMate , the leader in payments infrastructure as a service, to offer Medius customers an integrated and seamless way to make international payments without leaving their existing spend management platform. This agreement utilizes TransferMate’s globally regulated

Kemira invests to add capacity in water treatment chemicals to serve the growing Asia-Pacific market

Kemira Oyj, Press release, June 30, 2021 at 10 am EESTKemira, a global leader in sustainable chemical solutions for water intensive industries, is increasing production capacity of water treatment chemicals in Yanzhou, China. These investments are another step forward in the execution of Kemira’s growth strategy and serve the growing water treatment demand in China and the Asia-Pacific region.  Kemira continues to strengthen its position in the Asia-Pacific (APAC) market and announces two investments to add capacity in water treatment chemicals at its Yanzhou site in China.   Kemira

The Nomination Committee’s proposal for election of Board members

The Nomination Committee of SpectrumOne AB (publ) has decided to propose that the Annual General Meeting 2021 approve the following proposals regarding the number of Board members and election of Board members. The Nomination Committee proposes that the number of Board members be four (4). For the period until the end of the next Annual General Meeting, the Nomination Committee proposes re-election of Board members Fredric Forsman, Anders Hugosson, Hosni Teque-Omeirat, and furthermore proposes that Cecilia Hjertzell be elected as a new Board member. Erik Fagerlid has declined re-

Cyxone explores expanding into new regions to mitigate potential delay in Covid-19 trial completion

Cyxone initiated a clinical trial in Eastern Europe with Rabeximod as a treatment for patients with moderate Covid-19 in January 2021. Approximately 90 patients have been successfully enrolled to date. With the declining number of hospitalized Covid-19 patients in Eastern Europe, Cyxone is now considering opening up trial sites in more countries and has had to push back the projected study readout later than Q3 2021.After discovering that the rheumatoid arthritis drug candidate Rabeximod, could be effective in patients with moderate Covid-19, Cyxone started a Phase 2 clinical trial in

AAK enters formal consultation process regarding production consolidation to further optimize its European bakery business

AAK has entered a formal consultation process with union delegates to carry out a production consolidation and subsequent closure of its site in Merksem, Belgium. The suggested initiative is in line with the company’s strategy to optimize performance within the Bakery segment to improve cost efficiency and increase competitiveness. The production site in Merksem, Belgium, which employs approximately 100 people, is predominantly a bakery fats plant, mainly producing margarines and shortenings for the industrial market in continental Europe. The proposed consolidation implies a transfer of

Enersense has completed the sale of the entire share capital of Värväämö Oy to Citywork – Mika Linnamäki will leave the Management Team

Enersense International PlcStock Exchange Release 30 June 2021 at 9.55 a.m.Enersense International Plc, a provider of zero-emission energy solutions, has today completed the sale of the entire share capital of its subsidiary Värväämö Oy, which offers personnel services for the construction industry, to Citywork Oy. The sale was announced on 6 May 2021. As a result of the transaction, the Staff Leasing business area, part of Enersense’s Smart Industry segment, will be closed down and Mika Linnamäki, who led the business, will leave Enersense's Management Team and the company. “I warmly

UpCloud’s new Head of Sales Erik Rehn will lead the sales transformation towards the SMBs user segment

[Helsinki, Finland, 30.6.2021] UpCloud, a European cloud service provider for small and medium-sized companies, has just announced the appointment of Erik Rehn as its new Head of Sales.UpCloud is delighted to announce Erik Rehn joining the company as its new Head of Sales. As a part of UpCloud’s global team, Erik Rehn will be leading UpCloud's sales and business development strategy towards the company’s key user segments among small and medium-sized businesses as well as looking for new market opportunities.  "Not all companies are able or want to use the biggest cloud providers. Either

CELLINK has been granted its first patent of robotic systems for personalized and automated aesthetic medical procedures

CELLINK has been granted a patent for a unique set of robotic systems for transcutaneous delivery of substances, such as cosmetic or surgical fillers, into patients. This is CELLINK’s first granted patent in the field of personalized and automated aesthetic medical procedures - combining the strengths of 3D bioprinting, biomaterials, robotics, automation, and artificial intelligence to optimally administer substances, such as dermal fillers, into subcutaneous regions to improve aesthetical outcomes in patients. This is one technological example of the power of Bioconvergence. This patent

Vestas wins 219 MW order in the USA

News release from Vestas-American Wind TechnologyPortland, 30 June 2021 Vestas has received an order from an undisclosed customer for two wind projects in the USA totalling 219 MW. One project consists of 26 V150-4.2 MW turbines while the other includes 22 V150-4.2 MW and three V136-4.2 MW turbines, with all turbines delivered in 4.3 MW operating mode. “This order builds on the success that the V150-4.2 MW wind turbine has had both in the USA and globally and cements its position as one of the most applicable large wind turbines in the market,” said Jeff Fuchs, Vice President of

BioStock: CombiGene announces several milestones for CG01

Lund-based gene therapy company CombiGene continues to advance its main project CG01 ahead of the phase I studies scheduled to begin next year. The company is now ready for GMP production of drug substance and has also begun a collaboration with UK-based Neurochase in order to optimise the administration of the candidate.Read the full article at biostock.se: https://www.biostock.se/en/combigene-announces-several-milestones-for-cg01/This is a press release from BioStock - Connecting Innovation & Capital.https://www.biostock.se

Conference call interim report

Invitation to attend Vitrolife’s conference call regarding presentation of the interim report January – June 2021. The presentation will be held in English.Time: Thursday 15 July, 2021 at 10.00 a.m. CET.Registration can preferably be done 10-15 minutes before the conference start time on:Sweden dial in number: +46 (0)8 566 184 67International dial in number: +44 (0) 2071 928338Conference name: Vitrolife, conference ID: 1295747Vitrolife participants:Thomas Axelsson, CEOMikael Engblom, CFOThe press release for Vitrolife’s interim report will be released at 8.00 CET on the same

Conversion of shares

According to Beijer Ref AB’s Articles of Association, the owner of a Class A share has the right to request that the share should be converted into Class B share. At the request of shareholders, 360 000 Class A shares have been converted into 360 000 Class B shares. Through the reclassification, the total number of votes in the company decreases. After the conversion, the total number of shares and votes in Beijer Ref amounts to 382 304 070 shares and 633 909 510 votes, respectively. 27 956 160 of these shares are A shares, representing 279 561 600 votes, and 354 347 910 are B shares,

New York City Department of Sanitation to purchase seven Mack® LR Electric models

Volvo Group’s subsidiary Mack Trucks announced today that the New York City Department of Sanitation (DSNY) plans to purchase seven Mack® LR Electric refuse models, which will operate in each of the city’s boroughs. Mack made the announcement during WasteExpo 2021, June 28-30 at the Las Vegas Convention Center.DSNY  took delivery of its first fully electric refuse vehicle, a Mack LR Electric demonstration model, in September 2020 , when it began rigorous real-world

Alligator Bioscience AB and Scandion Oncology A/S present promising preclinical data

Lund, Sweden, June 30, 2021 – Alligator Bioscience (Nasdaq Stockholm: ATORX) and Scandion Oncology (Nasdaq Stockholm: SCOL) today announces promising preclinical data from their ongoing collaboration exploring the anti-tumor effects on drug resistant cancer by combining Scandion Oncology’s drug candidate SCO-101 and Alligator Bioscience’s candidate drug mitazalimab.The collaboration explores the anti-tumor efficacy of the CD40 antibody mitazalimab in combination with SCO-101 as an addition to chemotherapy (FOLFIRINOX) in chemotherapy-resistant preclinical tumor models. The hypothesis is

Atlas Copco’s Q2 report 2021 and invitation to conference call, July 16

Nacka, Sweden, June 30, 2021: Atlas Copco will publish its Q2 results for 2021 on Friday, July 16, at approximately 13:30 PM CEST. A conference call for investors, analysts and media will be held at 14:30 PM CEST.Participating from Atlas Copco will be Mats Rahmström, President and CEO, and Hans Ola Meyer, CFO. The conference call will begin with a short presentation of the report followed by a question-and-answer session. The conference call will be broadcasted live on the web. Please see our website www.atlascopcogroup.com/investor-relations for the webcast link and presentation

Mentice appoints Gunilla Andersson as Chief Financial Officer (CFO)

Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on image guided interventions, appoints Gunilla Andersson as CFO, effective September 1[st], 2021. Mentice AB is pleased to announce the appointment of Gunilla Andersson as its CFO. Gunilla will be responsible for finance, accounting, business intelligence and IT.  “I am excited to have Gunilla assume the role as CFO for Mentice, says Göran Malmberg, Mentice CEO, her experience from growth companies in the size bracket above us is very relevant and will be instrumental for

Change in the total number of shares and votes in IRRAS AB

Stockholm, June 30, 2021 - IRRAS, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, today announced that as of 30 June 2021, the total number of shares and votes in IRRAS AB amounts to 79,481,340. The number of shares and votes in IRRAS AB has increased as a result of the registration of 13,200,000 ordinary shares, which i accordance with previously announced information was issued in connection with the directed share issue carried out by the company on 10 June 2021. About IRRASIRRAS is a global medical care

Change in the number of shares and votes in Epiroc AB

Stockholm, Sweden: During June 2021, the number the number of outstanding shares in Epiroc AB decreased to 1 213 738 703 from 2 427 477 406 and the number of votes to 862 763 138.9 from 1 725 526 277.8. The change is the result of the 2:1 share split and redemption resolved by the Annual General Meeting on April 28, 2021, which have now concluded.Following the split and redemption, there are 823 765 854 series A shares in the company and 389 972 849 series B shares, corresponding to the number of shares in Epiroc AB before the share split and redemption. The redemption shares resulting

Scandion Oncology A/S and Alligator Bioscience AB present promising preclinical data

Copenhagen, Denmark, June 30, 2021 – Scandion Oncology (Nasdaq Stockholm: SCOL) and Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced promising preclinical data from their ongoing collaboration exploring the anti-tumor effects on drug resistant cancer by combining Scandion Oncology’s drug candidate SCO-101 and Alligator Bioscience’s candidate drug mitazalimab.The collaboration explores the anti-tumor efficacy of the CD40 antibody mitazalimab in combination with SCO-101 as an addition to chemotherapy (FOLFIRINOX) in chemotherapy-resistant preclinical tumor models. The

There are no items matching the current filter
There are no more items matching the current filter
Back to top